CVE-2026-53829: high-severity vulnerability in OpenClaw
OpenClaw < 2026.5.18 - Command Truncation in Exec Approval Display
Published · Updated
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 8.5epss 0.4%
exploitation probability
0.4%top 66% of all CVEs
observed exploitation
nono source reports it
OpenClaw before 2026.5.18 contains an approval display truncation vulnerability allowing authenticated users to hide command suffixes from approvers. Attackers can submit oversized exec commands with benign prefixes and malicious suffixes to execute unauthorized operations after approval.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
Affected products
OpenClaw · OpenClawRelated CVEs — OpenClaw
In the same product, most dangerous first.
CVE-2026-25253HIGHCVE-2026-25253EPSS 24.4%CVE-2026-32917CRITICALOpenClaw < 2026.3.13 - Remote Command Injection via Unsanitized iMessage Attachment Paths in SCPEPSS 3.2%CVE-2026-53822HIGHOpenClaw < 2026.5.18 - Command Argument Modification via Shell Wrapper Between Approval and ExecutionEPSS 2.0%CVE-2026-32052MEDIUMOpenClaw < 2026.2.24 - Hidden Command Execution via Shell-Wrapper Positional argv CarriersEPSS 1.6%CVE-2026-44998LOWOpenClaw < 2026.4.20 - Tool Policy Bypass via Bundled MCP/LSP ToolsEPSS 1.2%CVE-2026-44109CRITICALOpenClaw < 2026.4.15 - Authentication Bypass in Feishu Webhook and Card-Action ValidationEPSS 1.1%